-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VopjymzV0DN5y6kpAMX6zh4HDVTV+1JscO6Fy2quIf75S4CaKlG92/ZrjDQelV3H vWAAyd7tee52s0QwW4OUnw== 0001127602-09-023875.txt : 20091201 0001127602-09-023875.hdr.sgml : 20091201 20091201121851 ACCESSION NUMBER: 0001127602-09-023875 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091111 FILED AS OF DATE: 20091201 DATE AS OF CHANGE: 20091201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ordemann Thomas CENTRAL INDEX KEY: 0001430965 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-28740 FILM NUMBER: 091214182 MAIL ADDRESS: STREET 1: C/O BIOSCRIP, INC. STREET 2: 100 CLEARBROOK ROAD CITY: ELMSFORD STATE: X1 ZIP: 10523 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioScrip, Inc. CENTRAL INDEX KEY: 0001014739 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050489664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CLEARBROOK ROAD CITY: ELMSFORD STATE: NY ZIP: 10523 BUSINESS PHONE: 914 460 1600 MAIL ADDRESS: STREET 1: 100 CLEARBROOK ROAD CITY: ELMSFORD STATE: NY ZIP: 10523 FORMER COMPANY: FORMER CONFORMED NAME: MIM CORP DATE OF NAME CHANGE: 19960516 4/A 1 form4a.xml PRIMARY DOCUMENT X0303 4/A 2009-11-11 2009-11-12 0001014739 BioScrip, Inc. BIOS 0001430965 Ordemann Thomas 100 CLEARBROOK ROAD ELMSFORD NY 10523 1 Executive Vice President Common Stock, $.0001 Par Value 2009-11-11 4 S 0 41260 8.5604 D 20250 D Option To Purchase Common Stock 5.46 2008-08-01 2017-08-01 Common Stock, $.0001 Par Value 80000 80000 D Option To Purchase Common Stock 6.52 2009-04-29 2018-04-29 Common Stock, $.0001 Par Value 50625 50625 D Option To Purchase Common Stock 2.73 2010-04-28 2019-04-28 Common Stock, $.0001 Par Value 75000 75000 D Shares were sold at various prices between $8.49 and $8.60 per share. The reporting person undertakes to provide (upon request by the SEC staff, the issuer, or a security holder of the issuer) full information regarding the number of shares purchased or sold at each separate price. Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant. /s/ Thomas Ordemann 2009-12-01 -----END PRIVACY-ENHANCED MESSAGE-----